Combustible and Electronic Cigarette Exposures Increase ACE2 Activity and SARS-CoV-2 Spike Binding

Public Deposited
Analytics

Downloadable Content

Download PDF
Request Version for Screen Reader
Creator
  • Ghosh A.
    • Affiliation: University of North Carolina at Chapel Hill
  • Girish V.
    • Other Affiliation: Cold Spring Harbor Laboratory
  • Yuan M.L.
    • Other Affiliation: Cold Spring Harbor Laboratory
  • Coakley R.D.
    • Affiliation: University of North Carolina at Chapel Hill
  • Wrennall J.A.
    • Affiliation: University of North Carolina at Chapel Hill
  • Alexis N.E.
    • Affiliation: University of North Carolina at Chapel Hill
  • Sausville E.L.
    • Other Affiliation: Cold Spring Harbor Laboratory
  • Vasudevan A.
    • Other Affiliation: Cold Spring Harbor Laboratory
  • Chait A.R.
    • Other Affiliation: Cold Spring Harbor Laboratory
  • Sheltzer J.M.
    • Other Affiliation: Cold Spring Harbor Laboratory
  • Tarran R.
    • Affiliation: University of North Carolina at Chapel Hill
Abstract
  • To the Editor: The outbreak of coronavirus disease (COVID-19) has extensively impacted global health. The spike protein on the surface of the causative pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to the angiotensin-converting enzyme 2 (ACE2) receptor, a metallocarboxypeptidase, which is expressed in both mACE2 (membrane-anchored ACE2) and sACE2 (soluble ACE2) forms in the lung. Although mACE2 is responsible for viral entry, recent observations also suggest that sACE2 is involved, by its interaction with the spike protein, followed by receptor-mediated endocytosis of the viral particles (1). Tobacco use has been speculated as a risk factor for contracting SARS-CoV-2 infection and subsequent disease severity (2, 3), and electronic cigarettes (e-cigarettes) have been shown to induce harmful proteomic and immune changes in the lungs of vapers (4). In addition, the effect of vaping, and the role of nicotine, in the regulation of ACE2 expression has been demonstrated in animal models and cell culture systems (5–8). We therefore tested the hypothesis that combustible tobacco (e.g., cigarettes) and noncombustible e-cigarettes could affect ACE2 activity and subsequent SARS-CoV-2 infection. Some of our data have been reported previously at an international conference (9) and deposited in a preprint repository (https://doi.org/10.1101/2021.06.04.447156).
Date of publication
Keyword
DOI
Identifier
Resource type
  • Article
Rights statement
  • In Copyright
License
  • Attribution-NonCommercial-NoDerivs 4.0 International
Journal title
  • American Journal of Respiratory and Critical Care Medicine
Journal volume
  • 205
Journal issue
  • 1
Page start
  • 129
Page end
  • 133
Language
  • English
Version
  • Publisher
Funder
  • National Institutes of Health, NIH
  • U.S. Food and Drug Administration, FDA, (HL120100, HL153698)
  • New York Community Trust, NYCT
  • National Heart, Lung, and Blood Institute, NHLBI, (1DP5OD021385, HL135642, R01CA237652)
  • American Cancer Society, ACS
ISSN
  • 1073-449X
Publisher
  • American Thoracic Society

Relations

Parents:

This work has no parents.

In Collection:

Items

Thumbnail Title Date Uploaded Visibility Actions
file details rccm.202106-1377LE.pdf 2023-06-08 Public Download